<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Russian Journal of Genetics</journal-id><journal-title-group><journal-title xml:lang="en">Russian Journal of Genetics</journal-title><trans-title-group xml:lang="ru"><trans-title>Генетика</trans-title></trans-title-group></journal-title-group><issn publication-format="print">0016-6758</issn><issn publication-format="electronic">3034-5103</issn><publisher><publisher-name xml:lang="en">The Russian Academy of Sciences</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">666827</article-id><article-id pub-id-type="doi">10.31857/S0016675823070068</article-id><article-id pub-id-type="edn">QKHDWL</article-id><article-categories><subj-group subj-group-type="toc-heading"><subject>ОБЗОРНЫЕ И ТЕОРЕТИЧЕСКИЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">Mitochondrial DNA Mutations in Cardiovascular Diseases</article-title><trans-title-group xml:lang="ru"><trans-title>Мутации митохондриальной ДНК при заболеваниях сердечно-сосудистой системы</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Korepanov</surname><given-names>V. A.</given-names></name><name xml:lang="ru"><surname>Корепанов</surname><given-names>В. А.</given-names></name></name-alternatives><email>vakorep41811@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Rebrova</surname><given-names>T. Yu.</given-names></name><name xml:lang="ru"><surname>Реброва</surname><given-names>Т. Ю.</given-names></name></name-alternatives><email>vakorep41811@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Batalov</surname><given-names>R. E.</given-names></name><name xml:lang="ru"><surname>Баталов</surname><given-names>Р. Е.</given-names></name></name-alternatives><email>vakorep41811@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Afanasiev</surname><given-names>S. A.</given-names></name><name xml:lang="ru"><surname>Афанасьев</surname><given-names>С. А.</given-names></name></name-alternatives><email>vakorep41811@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Science</institution></aff><aff><institution xml:lang="ru">Научно-исследовательский институт кардиологии, Томский национальный исследовательский медицинский центр Российской академии наук</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2023-07-01" publication-format="electronic"><day>01</day><month>07</month><year>2023</year></pub-date><volume>59</volume><issue>7</issue><fpage>735</fpage><lpage>740</lpage><history><date date-type="received" iso-8601-date="2025-02-26"><day>26</day><month>02</month><year>2025</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2023, В.А. Корепанов, Т.Ю. Реброва, Р.Е. Баталов, С.А. Афанасьев</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2023, В.А. Корепанов, Т.Ю. Реброва, Р.Е. Баталов, С.А. Афанасьев</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="en">В.А. Корепанов, Т.Ю. Реброва, Р.Е. Баталов, С.А. Афанасьев</copyright-holder><copyright-holder xml:lang="ru">В.А. Корепанов, Т.Ю. Реброва, Р.Е. Баталов, С.А. Афанасьев</copyright-holder></permissions><self-uri xlink:href="https://transsyst.ru/0016-6758/article/view/666827">https://transsyst.ru/0016-6758/article/view/666827</self-uri><abstract xml:lang="en"><p id="idm45181324639472">Early prevention of development and timely diagnosis of diseases of the cardiovascular system are some of the main tasks of modern cardiology. One of the promising approaches is aimed at identifying associations between the carriage of mitochondrial DNA (mtDNA) mutations and the development of cardiovascular diseases. Mitochondria are the only source of energy accumulation in cardiomyocytes; therefore, failure of their functioning, caused by mtDNA mutations, directly affects the bioenergetics and the work of myocardial cells. The purpose of this review is to describe the current achivements in the study of associations of mutant mtDNA with the development of various pathologies of the cardiovascular system.</p></abstract><trans-abstract xml:lang="ru"><p id="idm45181324637520">Ранняя профилактика развития и своевременная диагностика болезней сердечно-сосудистой системы являются одними из основных задач современной кардиологии. Один из перспективных подходов направлен на выявление ассоциаций между носительством мутаций митохондриальной ДНК и развитием сердечно-сосудистых заболеваний. Митохондрии являются единственным источником аккумуляции энергии в кардиомиоцитах, поэтому нарушение их работы, обусловленное мутациями мтДНК, непосредственно отражается на биоэнергетике и работе клеток миокарда. Целью данного обзора стало описание современных достижений в исследовании ассоциаций мутантных мтДНК с развитием различных патологий сердечно-сосудистой системы.</p></trans-abstract><kwd-group xml:lang="en"><kwd>mitochondria</kwd><kwd>mutations</kwd><kwd>mitochondrial DNA</kwd><kwd>cardiovascular diseases.</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>митохондрии</kwd><kwd>мутации</kwd><kwd>митохондриальная ДНК</kwd><kwd>сердечно-сосудистые заболевания.</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Townsend N., Kazakiewicz D., Lucy Wright F. et al. Epidemiology of cardiovascular disease in Europe // Nat. Rev. Cardiol. 2022. № 19. P. 133–143. https://doi.org/10.1038/s41569-021-00607-3</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Hinton W., McGovern A., Coyle R. et al. Incidence and prevalence of cardiovascular disease in English primary care: A cross-sectional and follow-up study of the Royal College of General Practitioners (RCGP) Research and Surveillance Centre (RSC) // BMJ Open. 2018. № 8. e020282. https://doi.org/10.1136/bmjopen-2017-020282</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Бойцов С.А., Драпкина О.М., Шляхто Е.В. и др. Исследование ЭССЕ-РФ (Эпидемиология сердечно-сосудистых заболеваний и их факторов риска в регионах Российской Федерации). Десять лет спустя // Кардиоваскулярная терапия и профилактика. 2021. Т. 20. № 5. С. 3007.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Hanft L.M., Emter C.A., McDonald K.S. Cardiac myofibrillar contractile properties during the progression from hypertension to decompensated heart failure // Am. J. Physiol. Heart. Circ. Physiol. 2017. V. 313. № 1. P. H103–H113. https://doi.org/10.1152/ajpheart.00069.2017</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Cao Y.P., Zheng M. Mitochondrial dynamics and inter-mitochondrial communication in the heart // Arch. Biochem. Biophys. 2019. V. 663. P. 214–219. https://doi.org/10.1016/j.abb.2019.01.017</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Иванов К.П. Современные медицинские проблемы энергообмена у человека // Вестник РАМН. 2013. № 6. С. 56–59.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Alston C.L., Rocha M.C., Lax N.Z. et al. The genetics and pathology of mitochondrial disease // J. Pathol. 2017. V. 241. № 2. P. 236–250. https://doi.org/10.1002/path.4809</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Luft R., Ikkos D., Palmieri G. et al. A case of severe hypermetabolism of nonthyroid origin with a defect in the maintenance of mitochondrial respiratory control: A correlated clinical, biochemical, and morphological study // J. Clin. Invest. 1962. V. 41. № 9. P. 1776–804. https://doi.org/10.1172/JCI104637</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Nass M.M., Nass S. Intramitochondrial fibers with DNA characteristics. I. Fixation and electron staining reactions // J. Cell. Biol. 1963. V. 19. № 3. P. 593–611. https://doi.org/10.1083/jcb.19.3.593</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Wallace D.C., Singh G., Lott M.T. et al. Mitochondrial DNA mutation associated with Leber’s hereditary optic neuropathy // Science. 1988. V. 242. № 4884. P. 1427–1430. https://doi.org/10.1126/science.3201231</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Понасенко А.В., Цепокина А.В., Тхоренко Б.А. и др. Изменчивость митохондриальной ДНК в развитии атеросклероза и инфаркта миокарда (обзор литературы) // Комплексные проблемы сердечно-сосудистых заболеваний. 2018. Т. 7. № 4S. С. 75–85.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Mancuso M., Orsucci D., Angelini C. et al. The m.3243A&gt;G mitochondrial DNA mutation and related phenotypes. A matter of gender? // J. Neurol. 2014. V. 261. № 3. P. 504–510. https://doi.org/10.1007/s00415-013-7225-3</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Ng Y.S., Grady J.P., Lax N.Z. et al. Sudden adult death syndrome in m.3243A&gt;G-related mitochondrial disease: An unrecognized clinical entity in young, asymptomatic adults // Eur. Heart. J. 2016. V. 37. № 32. P. 2552–2559. https://doi.org/10.1093/eurheartj/ehv306</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Sazonova M.A., Sinyov V.V., Ryzhkova A.I. et al. MtDNA mutations linked with left ventricular hypertrophy // Vessel Plus. 2019. № 3. P. 5. https://doi.org/10.20517/2574-1209.2018.56</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Qi Y., Wu Z., Bai Y. et al. Screening for mitochondrial tRNA mutations in 318 patients with dilated cardiomyopathy // Hum. Hered. 2022. V. 87. P. 1–11. https://doi.org/10.1159/000521615</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Brambilla A., Olivotto I., Favilli S. et al. Impact of cardiovascular involvement on the clinical course of paediatric mitochondrial disorders // Orphanet J. Rare Dis. 2020. V. 15. № 1. P. 196. https://doi.org/10.1186/s13023-020-01466-w</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Гетман С.И. Распространенность нарушений ритма сердца и проводимости среди обратившихся за медицинской помощью к кардиологу на амбулаторном этапе // Кардиология. 2018. Т. 58. № 6. С. 20–28.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Deo R., Albert C.M. Epidemiology and genetics of sudden cardiac death // Circulation. 2012. V. 125. P. 620–637. https://doi.org/0.1161/CIRCULATIONAHA.111.023838</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Kytövuori L., Junttila J., Huikuri H. et al. Mitochondrial DNA variation in sudden cardiac death: A population-based study // Int. J. Legal. Med. 2020. V. 134. № 1. P. 39–44. https://doi.org/10.1007/s00414-019-02091-4</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Khatami F., Mehdi Heidari M., Houshmand M. The mitochondrial DNA mutations associated with cardiac arrhythmia investigated in an LQTS family // Iran J. Basic. Med. Sci. 2014. V. 17. № 9. P. 656–661.</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Niedermayr K., Pölzl G., Scholl-Bürgi S. et al. Mitochondrial DNA mutation “m.3243A&gt;G”. Heterogeneous clinical picture for cardiologists (“m.3243A&gt;G”: A phenotypic chameleon) // Congenit. Heart. Dis. 2018. V. 13. № 5. P. 671–677. https://doi.org/10.1111/chd.12634</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Li X., Liu M., Sun R. et al. Atherosclerotic coronary artery disease: The accuracy of measures to diagnose preclinical atherosclerosis // Exp. Theor. Med. 2016. V. 12. № 5. P. 2899–2902. https://doi.org/10.3892/etm.2016.3710</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Nishigaki Y., Yamada Y., Fuku N. et al. Mitochondrial haplogroup A is a genetic risk factor for atherothrombotic cerebral infarction in Japanese females // Mitochondrion. 2007. V. 7. № 1–2. P. 72–79. https://doi.org/10.1016/j.mito.2006.11.002</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Nishigaki Y., Yamada Y., Fuku N. et al. Mitochondrial haplogroup N9b is protective against myocardial infarction in Japanese males // Hum. Genet. 2007. V. 120. № 6. P. 827–836. https://doi.org/10.1007/s00439-006-0269-z</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Sazonova M.A., Sinyov V.V., Ryzhkova A.I. et al. Role of mitochondrial genome mutations in pathogenesis of carotid atherosclerosis // Oxid. Med. Cell Longev. 2017. V. 2017. P. 6934394. https://doi.org/10.1155/2017/6934394</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Liu C., Yang Q., Hwang S.J. et al. Association of genetic variation in the mitochondrial genome with blood pressure and metabolic traits // Hypertension. 2012. V. 60. № 4. P. 949–956. https://doi.org/10.1161/Hypertensionaha.112.196519</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Jia Z., Zhang Y., Li Q. et al. A coronary artery disease-associated tRNAThr mutation altered mitochondrial function, apoptosis and angiogenesis // Nucl. Ac. Res. 2019. V. 47. № 4. P. 2056–2074. https://doi.org/10.1093/nar/gky1241</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Zhu Q., Chen C., Yao J. Kearns–Sayre syndrome with a novel large-scale deletion: A case report // BMC Ophthalmol. 2022. V. 22. № 1. P. 35. https://doi.org/10.1186/s12886-021-02224-7</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>Khambatta S., Nguyen D.L., Beckman T.J., Wittich C.M. Kearns–Sayre syndrome: A case series of 35 adults and children // Int. J. Gen. Med. 2014. № 7. P. 325–332. https://doi.org/10.2147/IJGM.S65560</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>Mancuso M., Orsucci D., Filosto M. et al. Drugs and mitochondrial diseases: 40 queries and answers // Expert. Opin. Pharmacother. 2012. V. 13. № 4. P. 527–543.</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>Komura K., Nakano K., Ishigaki K. et al. Creatine monohydrate therapy in a Leigh syndrome patient with A8344G mutation // Pediatr. Int. 2006. V. 48. № 4. P. 409–412.</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>Kaur S., Nagpal M. Recent advancement in human reproduction three-parent babies: A technique to neutralize mitochondrial disease load-A boon or a bane for society? // Curry Trends Diagn. Treat. 2017. V. 1. № 2. P. 100–103.</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation>Labarta E., de Los Santos M.J., Escribá M.J. et al. Mitochondria as a tool for oocyte rejuvenation // Fertil. Steril. 2019. V. 111. № 2. P. 219–226.</mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation>Neupane J., Vandewoestyne M., Ghimire S. et al. Assessment of nuclear transfer techniques to prevent the transmission of heritable mitochondrial disorders without compromising embryonic development competence in mice // Mitochondrion. 2014. V. 18. P. 27–33.</mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation>Wolf D.P., Mitalipov N., Mitalipov S. Mitochondrial replacement therapy in reproductive medicine // Trends Mol. Med. 2015. V. 21. № 2. P. 68–76. https://doi.org/10.1016/j.molmed.2014.12.001</mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation>Hyslop L.A., Blakeley P., Craven L. et al. Towards clinical application of pronuclear transfer to prevent mitochondrial DNA disease // Nature. 2016. V. 534. P. 383–386.</mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation>Zaidi A.A., Makova K.D. lnvestigating mitonuclear interactions in human admixed populations // Nat. Ecol. Evol. 2019. № 3. P. 213–222. https://doi.org/0.1038/s41559-018-0766-1</mixed-citation></ref></ref-list></back></article>
